{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:29:56Z","timestamp":1648582196669},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,7,5]],"date-time":"2008-07-05T00:00:00Z","timestamp":1215216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2008,7,5]],"date-time":"2008-07-05T00:00:00Z","timestamp":1215216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s12308-008-0008-6","type":"journal-article","created":{"date-parts":[[2008,7,4]],"date-time":"2008-07-04T13:22:35Z","timestamp":1215177755000},"page":"85-95","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma"],"prefix":"10.1007","volume":"1","author":[{"given":"Heike","family":"St\u00f6cklein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grit","family":"Hutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Kalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiemo","family":"Katzenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Leich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"H\u00f6ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Konrad","family":"M\u00fcller-Hermelink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Dreyling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,7,5]]},"reference":[{"key":"8_CR1","doi-asserted-by":"crossref","unstructured":"(1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood 89:3909\u20133918","DOI":"10.1182\/blood.V89.11.3909"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1182\/blood.V89.6.2067","volume":"89","author":"LH Argatoff","year":"1997","unstructured":"Argatoff LH, Connors JM, Klasa RJ et al (1997) Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood 89:2067\u20132078","journal-title":"Blood"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z","volume":"82","author":"F Bosch","year":"1998","unstructured":"Bosch F, Lopez-Guillermo A, Campo E et al (1998) Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer 82:567\u201375","journal-title":"Cancer"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Wiestner A et al (2003) The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell 3:185\u2013197","journal-title":"Cancer Cell"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V78.2.259.bloodjournal782259","volume":"78","author":"M Raffeld","year":"1991","unstructured":"Raffeld M, Jaffe ES (1991) bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 78:259\u2013263","journal-title":"Blood"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.V76.7.1387.1387","volume":"76","author":"ME Williams","year":"1990","unstructured":"Williams ME, Westermann CD, Swerdlow SH (1990) Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood 76:1387\u20131391","journal-title":"Blood"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"P Jares","year":"2007","unstructured":"Jares P, Colomer D, Campo E (2007) Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 7:750\u2013762","journal-title":"Nat Rev Cancer"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","volume":"84","author":"F Bosch","year":"1994","unstructured":"Bosch F, Jares P, Campo E et al (1994) PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 84:2726\u20132732","journal-title":"Blood"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","volume":"13","author":"SE Bodrug","year":"1994","unstructured":"Bodrug SE, Warner BJ, Bath ML et al (1994) Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. Embo J 13:2124\u20132130","journal-title":"Embo J"},{"key":"8_CR10","first-page":"4365","volume":"93","author":"S Bea","year":"1999","unstructured":"Bea S, Ribas M, Hernandez JM et al (1999) Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 93:4365\u20134374","journal-title":"Blood"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1046\/j.1365-2141.2002.03260.x","volume":"116","author":"JE Allen","year":"2002","unstructured":"Allen JE, Hough RE, Goepel JR et al (2002) Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. Br J Haematol 116:291\u2013298","journal-title":"Br J Haematol"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1182\/blood-2003-12-4175","volume":"104","author":"H Kohlhammer","year":"2004","unstructured":"Kohlhammer H, Schwaenen C, Wessendorf S et al (2004) Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 104:795\u2013801","journal-title":"Blood"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U","volume":"21","author":"O Monni","year":"1998","unstructured":"Monni O, Oinonen R, Elonen E et al (1998) Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer 21:298\u2013307","journal-title":"Genes Chromosomes Cancer"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1182\/blood-2004-07-2730","volume":"105","author":"M Schraders","year":"2005","unstructured":"Schraders M, Pfundt R, Straatman HM et al (2005) Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood 105:1686\u20131693","journal-title":"Blood"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1200\/JCO.2006.08.4251","volume":"25","author":"I Salaverria","year":"2007","unstructured":"Salaverria I, Zettl A, Bea S et al (2007) Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol 25:1216\u20131222","journal-title":"J Clin Oncol"},{"issue":"18","key":"8_CR16","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1038\/sj.onc.1210901","volume":"27","author":"I St\u00f6cklein","year":"2008","unstructured":"St\u00f6cklein H, Smardova J, Macak J et al (2008) Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma. Oncogene 27(18):2613\u20132625","journal-title":"Oncogene"},{"key":"8_CR17","unstructured":"Jaffe E, Harris N, Stein H et al (2001) World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues."},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/gcc.20277","volume":"45","author":"G Hutter","year":"2006","unstructured":"Hutter G, Scheubner M, Zimmermann Y et al (2006) Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma. Genes Chromosomes Cancer 45:203\u2013210","journal-title":"Genes Chromosomes Cancer"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/0076-6879(95)54024-5","volume":"254","author":"P Lichter","year":"1995","unstructured":"Lichter P, Bentz M, Joos S (1995) Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization. Methods Enzymol 254:334\u2013359","journal-title":"Methods Enzymol"},{"key":"8_CR20","volume-title":"An international system for human cytogenetic nomenclature","author":"LG Shaffer","year":"2005","unstructured":"Shaffer LG, Tommerup N (2005) An international system for human cytogenetic nomenclature. S. Karger AG, Memphis, TN"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/00000478-199810000-00003","volume":"22","author":"T Rudiger","year":"1998","unstructured":"Rudiger T, Ott G, Ott MM et al (1998) Differential diagnosis between classic Hodgkin\u2019s lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry. Am J Surg Pathol 22:1184\u20131191","journal-title":"Am J Surg Pathol"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"JG Herman","year":"1996","unstructured":"Herman JG, Graff JR, Myohanen S et al (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93:9821\u20139826","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng1077","volume":"33","author":"WY Chen","year":"2003","unstructured":"Chen WY, Zeng X, Carter MG et al (2003) Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33:197\u2013202","journal-title":"Nat Genet"},{"key":"8_CR24","first-page":"1982","volume":"7","author":"SM Dong","year":"2001","unstructured":"Dong SM, Kim HS, Rha SH et al (2001) Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin Cancer Res 7:1982\u20131986","journal-title":"Clin Cancer Res"},{"key":"8_CR25","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ijc.20165","volume":"110","author":"A Waha","year":"2004","unstructured":"Waha A, Koch A, Hartmann W et al (2004) Analysis of HIC-1 methylation and transcription in human ependymomas. Int J Cancer 110:542\u2013549","journal-title":"Int J Cancer"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1002\/cncr.22715","volume":"109","author":"A Ferrer","year":"2007","unstructured":"Ferrer A, Salaverria I, Bosch F et al (2007) Leukemic involvement is a common feature in mantle cell lymphoma. Cancer 109:2473\u20132480","journal-title":"Cancer"},{"key":"8_CR27","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1200\/JCO.2005.05.019","volume":"23","author":"V Fernandez","year":"2005","unstructured":"Fernandez V, Hartmann E, Ott G et al (2005) Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol 23:6364\u20136369","journal-title":"J Clin Oncol"},{"key":"8_CR28","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1073\/pnas.68.4.820","volume":"68","author":"AG Knudson Jr","year":"1971","unstructured":"Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820\u2013823","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR29","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1056\/NEJMra023075","volume":"349","author":"JG Herman","year":"2003","unstructured":"Herman JG, Baylin SB (2003) Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349:2042\u20132054","journal-title":"N Engl J Med"},{"key":"8_CR30","first-page":"1141","volume":"87","author":"M Solenthaler","year":"2002","unstructured":"Solenthaler M, Matutes E, Brito-Babapulle V et al (2002) p53 and mdm2 in mantle cell lymphoma in leukemic phase. Haematologica 87:1141\u20131150","journal-title":"Haematologica"},{"key":"8_CR31","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1073\/pnas.0510441103","volume":"103","author":"TC Greiner","year":"2006","unstructured":"Greiner TC, Dasgupta C, Ho VV et al (2006) Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma. Proc Natl Acad Sci U S A 103:2352\u20132357","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8_CR32","first-page":"5572","volume":"59","author":"T Hashimoto","year":"1999","unstructured":"Hashimoto T, Tokuchi Y, Hayashi M et al (1999) p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas. Cancer Res 59:5572\u20135577","journal-title":"Cancer Res"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/path.1711660402","volume":"166","author":"D Wynford-Thomas","year":"1992","unstructured":"Wynford-Thomas D (1992) P53 in tumour pathology: can we trust immunocytochemistry? J Pathol 166:329\u2013330","journal-title":"J Pathol"},{"key":"8_CR34","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302","volume":"87","author":"TC Greiner","year":"1996","unstructured":"Greiner TC, Moynihan MJ, Chan WC et al (1996) p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 87:4302\u20134310","journal-title":"Blood"},{"key":"8_CR35","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","volume":"87","author":"L Hernandez","year":"1996","unstructured":"Hernandez L, Fest T, Cazorla M et al (1996) p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 87:3351\u20133359","journal-title":"Blood"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1182\/blood.V86.8.2892.2892","volume":"86","author":"DC Louie","year":"1995","unstructured":"Louie DC, Offit K, Jaslow R et al (1995) p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 86:2892\u20132899","journal-title":"Blood"},{"key":"8_CR37","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/sj.onc.1208300","volume":"24","author":"H Tagawa","year":"2005","unstructured":"Tagawa H, Karnan S, Suzuki R et al (2005) Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24:1348\u20131358","journal-title":"Oncogene"},{"key":"8_CR38","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/sj.leu.2400973","volume":"12","author":"M Sankar","year":"1998","unstructured":"Sankar M, Tanaka K, Kumaravel TS et al (1998) Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality. Leukemia 12:510\u2013516","journal-title":"Leukemia"},{"key":"8_CR39","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.ejca.2004.08.005","volume":"40","author":"A Cvekl Jr","year":"2004","unstructured":"Cvekl A Jr, Zavadil J, Birshtein BK et al (2004) Analysis of transcripts from 17p13.3 in medulloblastoma suggests ROX\/MNT as a potential tumour suppressor gene. Eur J Cancer 40:2525\u20132532","journal-title":"Eur J Cancer"},{"key":"8_CR40","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/sj.onc.1206304","volume":"22","author":"H Konishi","year":"2003","unstructured":"Konishi H, Sugiyama M, Mizuno K et al (2003) Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer. Oncogene 22:1892\u20131905","journal-title":"Oncogene"},{"key":"8_CR41","first-page":"1997","volume":"56","author":"DC Schultz","year":"1996","unstructured":"Schultz DC, Vanderveer L, Berman DB et al (1996) Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res 56:1997\u20132002","journal-title":"Cancer Res"},{"key":"8_CR42","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nm0695-570","volume":"1","author":"MM Wales","year":"1995","unstructured":"Wales MM, Biel MA, el Deiry W et al (1995) p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med 1:570\u2013577","journal-title":"Nat Med"},{"key":"8_CR43","first-page":"1678","volume":"57","author":"JP Issa","year":"1997","unstructured":"Issa JP, Zehnbauer BA, Kaufmann SH et al (1997) HIC1 hypermethylation is a late event in hematopoietic neoplasms. Cancer Res 57:1678\u20131681","journal-title":"Cancer Res"},{"key":"8_CR44","first-page":"3730","volume":"59","author":"JR Melki","year":"1999","unstructured":"Melki JR, Vincent PC, Clark SJ (1999) Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 59:3730\u20133740","journal-title":"Cancer Res"},{"key":"8_CR45","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1365-2141.2008.06992.x","volume":"141","author":"C Britschgi","year":"2008","unstructured":"Britschgi C, Jenal M, Rizzi M et al (2008) HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation. Br J Haematol 141:179\u2013187","journal-title":"Br J Haematol"},{"key":"8_CR46","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.ccr.2004.08.030","volume":"6","author":"W Chen","year":"2004","unstructured":"Chen W, Cooper TK, Zahnow CA et al (2004) Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 6:387\u2013398","journal-title":"Cancer Cell"},{"key":"8_CR47","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1054\/bjoc.2001.2164","volume":"85","author":"T Stokke","year":"2001","unstructured":"Stokke T, DeAngelis P, Smedshammer L et al (2001) Loss of chromosome 11q21\u201323.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin\u2019s lymphoma. Br J Cancer 85:1900\u20131913","journal-title":"Br J Cancer"},{"key":"8_CR48","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/0092-8674(91)90384-B","volume":"65","author":"J Milner","year":"1991","unstructured":"Milner J, Medcalf EA (1991) Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation. Cell 65:765\u2013774","journal-title":"Cell"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-008-0008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-008-0008-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12308-008-0008-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-008-0008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T19:41:19Z","timestamp":1630438879000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-008-0008-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s12308-008-0008-6","relation":{},"ISSN":["1865-5785","1865-5785"],"issn-type":[{"value":"1865-5785","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,5]]},"assertion":[{"value":"14 February 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}